Percutaneous Valve Technology in China: Experience, Present and Future (pp. 491-508)
Authors: (Xin Chen, Fuhuang Huang)
Abstract: Since its introduction 30 years ago by Andreas Gruntzig, interventional cardiology has expanded its scope from coronary disease to valve diseases gradually. And now, a variety of percutaneous methods to treat mitral regurgitation and to replace pulmonic and aortic valves have already been successfully employed in patients. In China, the first pulmonic balloon valvuloplasty was reported in 1985 and was rapidly followed by applications to the mitral valves and aortic valves. Moreover, percutaneous valve replacement has been developed in numerous studies in animal models recent years. In the future, these creative new transcatheter approaches may change the face of valve therapy in China.